title: The 9-arginine residue of alpha-conotoxin GI is responsible for its selective high affinity for the alphagamma agonist site on the electric organ acetylcholine receptor.
abstract: The two agonist-binding domains of the electric organ nicotinic acetylcholine receptor are located at the alphagamma and alphadelta subunit interfaces. alpha-Conotoxins GI and MI are competitive antagonists of this receptor and, like d-tubocurarine, bind to the alphagamma site with much higher affinity than to the alphadelta site. In the present study, alpha-conotoxin SIA also displayed strong affinity for the alphagamma site but no measurable affinity for the alphadelta site, thus showing even greater site-selectivity. In contrast, alpha-conotoxin SI does not distinguish between the two agonist sites, although its sequence differs from that of GI at only three positions: GI, ECCNPACGRHYSC; SI, ICCNPACGPKYSC. Analogues of SI and GI modified at these three positions were studied to identify the determinants of GI's alphagamma selectivity. Substituting arginine for proline at position 9 produced peptides which displayed "GI-like" selectivity for the alphagamma site. Conversely, substituting proline for arginine at position 9 resulted in "SI-like" nonselective inhibitors. An SI analogue having alanine in place of proline 9 did not distinguish between the two agonist sites and displayed about the same affinity as SI, indicating the importance of the arginyl cation. Interchanging the residues at position 1 or at position 10 influenced the affinity for the receptor but did not measurably change peptide selectivity. Therefore, of the three sequence differences in SI and GI, the variation at position 9, proline and arginine, respectively, is sufficient to account for GI's selective high-affinity binding to the alphagamma site on the electric organ acetylcholine receptor.
authors.affiliation: Department of Biochemistry and Center for Molecular and Behavioral Neuroscience, Universidad Central del Caribe, Bayamón, Puerto Rico 00960, USA.
authors.forename: R M
authors.initials: RM
authors.lastname: Hann
authors.forename: O R
authors.initials: OR
authors.lastname: Pagán
authors.forename: L M
authors.initials: LM
authors.lastname: Gregory
authors.forename: T
authors.initials: T
authors.lastname: Jácome
authors.forename: V A
authors.initials: VA
authors.lastname: Eterović
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D001120:Arginine / Q000378:metabolism*; D001496:Batrachotoxins / Q000378:metabolism; D001665:Binding Sites; D001667:Binding, Competitive; D018679:Cholinergic Agonists / Q000378:metabolism; D020916:Conotoxins; D004557:Electric Organ / Q000378:metabolism*; D008969:Molecular Sequence Data; D008978:Mollusk Venoms / Q000737:chemistry / Q000378:metabolism*; D010456:Peptides, Cyclic / Q000737:chemistry / Q000378:metabolism*; D011950:Receptors, Cholinergic / Q000737:chemistry / Q000378:metabolism*; D014101:Torpedo
chemical_list: D001496:Batrachotoxins; D018679:Cholinergic Agonists; D020916:Conotoxins; D008978:Mollusk Venoms; D010456:Peptides, Cyclic; D011950:Receptors, Cholinergic; C057819:conotoxin SI; C029960:conotoxin GI; D001120:Arginine